Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.
Castéra L, Loko MA, Le Bail B, Coffie P, De Ledinghen V, Trimoulet P, Winnock M, Dabis F, Neau D; Groupe D'epidémiologie Clinique du Sida en Aquitaine (GECSA). Castéra L, et al. Among authors: trimoulet p. Aliment Pharmacol Ther. 2007 Dec;26(11-12):1489-98. doi: 10.1111/j.1365-2036.2007.03533.x. Epub 2007 Sep 28. Aliment Pharmacol Ther. 2007. PMID: 17903235 Free article.
TT virus infection during chronic hepatitis C.
Trimoulet P, de Lédinghen V, Ekouevi D, Bernard PH, Merel P, Chêne G, Couzigou P, Fleury H. Trimoulet P, et al. Am J Gastroenterol. 2000 Jul;95(7):1765-9. doi: 10.1111/j.1572-0241.2000.02138.x. Am J Gastroenterol. 2000. PMID: 10925982
Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C.
Breilh D, Foucher J, Castéra L, Trimoulet P, Djabarouti S, Merrouche W, Couzigou P, Saux MC, de Lédinghen V. Breilh D, et al. Among authors: trimoulet p. Aliment Pharmacol Ther. 2009 Sep 1;30(5):487-94. doi: 10.1111/j.1365-2036.2009.04065.x. Epub 2009 Jun 11. Aliment Pharmacol Ther. 2009. PMID: 19523176 Free article.
Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.
de Lédinghen V, Trimoulet P, Winnock M, Foucher J, Bourlière M, Desmorat H, Canva V, Capron D, Lévy S, Mion F, Mannant PR, Chêne G, Fleury H, Couzigou P, Bernard PH; French Multicenter Study Group. de Lédinghen V, et al. Among authors: trimoulet p. J Hepatol. 2002 May;36(5):672-80. doi: 10.1016/s0168-8278(02)00026-0. J Hepatol. 2002. PMID: 11983451 Clinical Trial.
Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: long-term follow-up of 196 patients (4535 patient-years).
de Lédinghen V, Trimoulet P, Mannant PR, Dumas F, Champbenoît P, Baldit C, Foucher J, Faure M, Vergniol J, Castéra L, Bertet J, Fleury H, Couzigou P, Bernard PH. de Lédinghen V, et al. Among authors: trimoulet p. J Hepatol. 2007 Jan;46(1):19-25. doi: 10.1016/j.jhep.2006.07.029. Epub 2006 Sep 22. J Hepatol. 2007. PMID: 17030451
Daily or three times per week interferon alpha-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone.
de Lédinghen V, Trimoulet P, Winnock M, Bernard PH, Bourlière M, Portal I, Rémy AJ, Szostak N, Lévy S, Tran A, Abergel A, Chêne G, Fleury H, Couzigou P; French Multicenter Study Group. de Lédinghen V, et al. Among authors: trimoulet p. J Hepatol. 2002 Jun;36(6):819-26. doi: 10.1016/s0168-8278(02)00071-5. J Hepatol. 2002. PMID: 12044534 Clinical Trial.
135 results